ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420621 | Rec_0433279 | hoki frame antioxidant peptide |
ESTVPERTHPACPDFN |
Johnius belengerii [Animal] |
Antioxidant, Free-radical scavenging |
hydroxyl radical |
17.77 μM | IC50 (electron spin resonance radical-scavenging assay) |
16563720 | - |
YES |
| 420622 | Rec_0433280 | hoki frame antioxidant peptide |
ESTVPERTHPACPDFN |
Johnius belengerii [Animal] |
Antioxidant, Free-radical scavenging |
peroxyl radical |
18.99 μM | IC50 (electron spin resonance radical-scavenging assay) |
16563720 | - |
YES |
| 420623 | Rec_0433281 | hoki frame antioxidant peptide |
ESTVPERTHPACPDFN |
Johnius belengerii [Animal] |
Antioxidant, Free-radical scavenging |
superoxide radical |
172.10 μM | IC50 (electron spin resonance radical-scavenging assay) |
16563720 | - |
YES |
| 420624 | Rec_0433282 | Reutericin 6 |
IYWIADQFGIHLATGTARKLLDAMASGASLGTAFAAILGVTLPAWALAAAGALGATA |
Lactobacillus reuteri LA6 [Bacterium] |
Antimicrobial, Antibacterial, Bacteriolytic |
Lactobacillus delbrueckii subsp. bulgaricus JCM 1002T; Lactobacillus delbrueckii subsp. bulgaricus N1A1 B6 |
- | Bacteriolytic activity assay (turbidity decrease, viable-cell count and beta-galactosidase leakage) |
9039561 | - |
YES |
| 420625 | Rec_0433283 | KHN20 |
KHNLGHGHKHERDQGHGHQR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Zinc-potentiated antibacterial activity |
Enterococcus faecalis 2374 |
- | Viable-count antibacterial assay (0.03–60 μM peptide; ±50 μM Zn2+) |
16704414 | US 2007/0185019 A1 |
YES |
| 420626 | Rec_0433284 | SEQ ID NO:28 antimicrobial peptide |
GLLSKLGKAVKNILEDVV |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 |
100 % | Growth inhibition assay (0.1% arabinose induction; endpoint OD) |
- | US 2007/0259087 A1 |
YES |
| 420627 | Rec_0433285 | GN8 |
LRKFWKKIRKFLKKI |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-negative |
Pseudomonas aeruginosa |
8 μg/mL | MIC |
34349895 | - |
YES |
| 420628 | Rec_0433286 | GN8 |
LRKFWKKIRKFLKKI |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-negative |
Acinetobacter baumannii |
4 μg/mL | MIC |
34349895 | - |
YES |
| 420629 | Rec_0433287 | GN8 |
LRKFWKKIRKFLKKI |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive |
methicillin-resistant Staphylococcus aureus (MRSA) |
4 μg/mL | MIC |
34349895 | - |
YES |
| 420630 | Rec_0433288 | GN8 |
LRKFWKKIRKFLKKI |
synthetic construct [Synthetic] |
Hemolytic, Cytotoxic |
human red blood cells |
62.5 μg/mL | MHC (minimum hemolytic concentration) |
34349895 | - |
YES |
| 420631 | Rec_0433289 | GN8 |
LRKFWKKIRKFLKKI |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-negative |
Escherichia coli |
16 μg/mL | MIC |
34349895 | - |
YES |
| 420632 | Rec_0433290 | IA-2(646-663) T-cell epitope |
EGPPEPSRVSSVSSQFSD |
synthetic construct [Synthetic] |
T-cell epitope, Immunogenic, Type 1 diabetes-related |
HLA-DQ8-restricted CD4+ T cells in DQ8 transgenic mice |
- | Peptide immunization followed by CD4+ T-cell lymphoproliferative response assay |
11600216 | - |
YES |
| 420633 | Rec_0433291 | Influenza HA16 (90-106) CD4 T-cell epitope |
KESWSYIVETPNPENGT |
synthetic construct [Synthetic] |
T-cell epitope, Immunogenic, Antiviral immune epitope |
I-A^b-restricted mouse CD4+ T cells |
100±23 spots/10^6 T cells | IL-2 ELISPOT |
20373997 | - |
YES |
| 420634 | Rec_0433292 | halicylindramide B |
XXPVXWRXTXFTNG |
Halichondria cylindrata [Animal] |
Antifungal, Antimicrobial, Cytotoxic, Toxin |
Mortierella ramanniana |
7.5 μg/disk | antifungal disk assay |
7830276 | - |
YES |
| 420635 | Rec_0433293 | Unnamed |
GLLKRLGRKIGKKLKKFGQKIKAIRKLVP |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli |
100 % | growth inhibition assay (0.1% arabinose induction) |
- | US 2008/0213430 A1 |
YES |
| 420636 | Rec_0433294 | Ab2-4 |
LLWKLLKKLLK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Bactericidal |
Escherichia coli ML35p |
25 μg/mL | MBC |
- | US 2018/0141984 A1 |
YES |
| 420637 | Rec_0433295 | Peptide A (SEQ ID NO:1) |
KEXKPDGEQXGITDHNDXXNAXVXPDGPFMR |
Segestria sp. [Animal] |
Insecticidal, Paralytic toxin |
Heliothis virescens larvae |
10.0 μg/g | PD90 (abdominal injection paralysis bioassay) |
- | US 5674846 A |
YES |
| 420638 | Rec_0433296 | Cruzioseptin-11 |
GFLDIVKHVGKAAGKAALNAVTEMVNQ |
synthetic construct [Synthetic] |
Antiparasitic, Antitrypanosomal, Antimicrobial |
Trypanosoma cruzi X-1081 epimastigotes |
12.7±2.9 μM | IC50 (resazurin viability assay) |
40474242 | - |
YES |
| 420639 | Rec_0433297 | Cruzioseptin-11 |
GFLDIVKHVGKAAGKAALNAVTEMVNQ |
synthetic construct [Synthetic] |
Hemolytic |
human erythrocytes |
567.5±44.9 μM | CC50 (Hemolysis) |
40474242 | - |
YES |
| 420640 | Rec_0433298 | Pipinin III (brevinin-1Pc) |
FLFIIASVAAKVFSKIFCAISKKC |
Rana pipiens [Animal] |
Antimicrobial, Antibacterial |
Staphylococcus aureus NCTC 8325 |
7 μM | MIC |
10651828 | - |
YES |